We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current IMM market cap is 4.6M. The company's latest EPS is GBP -0.0070 and P/E is -1.54.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 78k | 127k | 118k | 0 | 0 |
| Operating Income | -6.81M | -5.59M | -6.59M | -3.03M | -3.06M |
| Net Income | -6.12M | -6.86M | -8.17M | -3.81M | -2.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 5.8M | 10.92M | 6M | 3.98M | 2.72M |
| Total Liabilities | 532k | 1.26M | 1.58M | 1.45M | 1.67M |
| Total Equity | 5.27M | 9.66M | 4.41M | 2.52M | 1.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -4.22M | -3.33M | -4.83M | -2.35M | -1.36M |
| Investing | -101k | -569k | -50k | -77k | 189k |
| Financing | 326k | 8.37M | 702k | 1.55M | 722k |
| Market Cap | 4.6M |
| Price to Earnings Ratio | -1.54 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 21.6 |
| Price to Book Ratio | 4.26 |
| Dividend Yield | - |
| Shares Outstanding | 416.44M |
| Average Volume (1 week) | 1.21M |
| Average Volume (1 Month) | 2.39M |
| 52 Week Change | -32.21% |
| 52 Week High | 2.90 |
| 52 Week Low | 0.83 |
| Spread (Intraday) | 0.11 (9.05%) |
| Company Name | Immupharma Plc |
| Address |
one bartholomew close london EC1A 7BL |
| Website | https://www.immupharma.com |
| Industry | finance diversified (F) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
